[1] Shah NA,Parveen S,Kadla S,et al.Genotype distribution of hepatitis C virus in patients with chronic hepatitis C infection in Kashmir:A cross sectional study.J Clin ExpHepatol,2016,16(6):S12-S13. [2] 吴春晓,周晓蕾,陈燕鸿,等. 乙型肝炎相关性原发性肝癌发生的危险因素分析. 实用肝脏病杂志,2015,18(3):306-307. [3] Islami F,Dikshit R,Mallath MK,et al.Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India. Cancer Epidemiol,2016,40:79-86. [4] 杨秉辉,丛文铭,周晓军,等. 原发性肝癌规范化诊治的专家共识. 实用肝脏病杂志,2009,10(5):321-328. [5] 杨家进,吴建兵. 原发性肝癌综合介入治疗进展. 实用肝脏病杂志,2015,16(2):118-119. [6] Yu MM,Jiang Q,Ji Y,et al.Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus. J Clin Virol,2014,61(1):55-60. [7] 沈中阳,朱志军,邓永林,等. 小剂量HBIg 联合核苷类似物预防肝移植术后乙型肝炎复发1506例回顾性分析. 中华肝胆外科杂志,2011,17(5):364-366. [8] Alejandro F,Josep MJ,Jordi B.Hepatocellular carcinoma. Lancet,2012,379(9822):1245-1255. |